Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (7,582,028)	$ (2,406,555)
Adjustments to reconcile net gain (loss) to net cash used in operating activities
Depreciation & Amortization	45,605
Impairment Loss	4,835,596
Stock-Based Compensation	10,000
Foreign Exchange Loss	(47,539)
Changes in
Due from Creative Edge Nutrition Inc.		167,456
Accounts Payable	102,978	613,248
Accrued Interest and Other Expenses	1,953,242	1,362,032
Cash Flows Used in Operating Activities	(682,146)	(263,819)
CASH FLOWS FROM INVESTING ACTIVITIES
Loans to CEN Ukraine	(425,328)
Leasehold Improvements In Progress	7,265	(47,672)
Purchase of Light Patent (paid in cash)	(7,837)
Total Cash Flows Used in Investing Activities	(425,900)	(47,672)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds From Convertible Loans	1,167,412	270,074
Total Cash Flows Provided by Financing Activities	1,167,412	270,074
Net increase (decrease)	59,366	(41,417)
Cash, Beginning of Period	3,016	44,433
Cash, End of Period	62,381	3,016
NON-CASH TRANSACTIONS
Loans Payable reclassified to Convertible Notes	206,541
Loans Payable- RP reclassified to Convertible Notes- RP	538,943
Accrued Expense reclassified to Notes Payable	105,206
Accrued Interest reclassified to Notes Payable	254,829
Construction in Progress exchanged for Patent	1,096,816
Land exchanged for Patent	1,064,651
Loans Payable exchanged for Patent	202,663
Stock Issued in exchange for Patent	3
Patent Acquired with above consideration	$ 2,364,133